1. Home
  2. TECX vs CMCO Comparison

TECX vs CMCO Comparison

Compare TECX & CMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • CMCO
  • Stock Information
  • Founded
  • TECX 2019
  • CMCO 1875
  • Country
  • TECX United States
  • CMCO United States
  • Employees
  • TECX N/A
  • CMCO N/A
  • Industry
  • TECX
  • CMCO Construction/Ag Equipment/Trucks
  • Sector
  • TECX
  • CMCO Industrials
  • Exchange
  • TECX Nasdaq
  • CMCO Nasdaq
  • Market Cap
  • TECX 387.1M
  • CMCO 430.3M
  • IPO Year
  • TECX 2018
  • CMCO 1996
  • Fundamental
  • Price
  • TECX $19.02
  • CMCO $15.30
  • Analyst Decision
  • TECX Buy
  • CMCO Hold
  • Analyst Count
  • TECX 6
  • CMCO 1
  • Target Price
  • TECX $79.17
  • CMCO $35.00
  • AVG Volume (30 Days)
  • TECX 515.4K
  • CMCO 288.1K
  • Earning Date
  • TECX 11-06-2025
  • CMCO 10-30-2025
  • Dividend Yield
  • TECX N/A
  • CMCO 1.90%
  • EPS Growth
  • TECX N/A
  • CMCO N/A
  • EPS
  • TECX N/A
  • CMCO N/A
  • Revenue
  • TECX N/A
  • CMCO $959,221,000.00
  • Revenue This Year
  • TECX N/A
  • CMCO $3.23
  • Revenue Next Year
  • TECX N/A
  • CMCO $5.02
  • P/E Ratio
  • TECX N/A
  • CMCO N/A
  • Revenue Growth
  • TECX N/A
  • CMCO N/A
  • 52 Week Low
  • TECX $13.70
  • CMCO $11.78
  • 52 Week High
  • TECX $61.07
  • CMCO $41.05
  • Technical
  • Relative Strength Index (RSI)
  • TECX 61.68
  • CMCO 54.12
  • Support Level
  • TECX $16.98
  • CMCO $14.51
  • Resistance Level
  • TECX $18.77
  • CMCO $15.73
  • Average True Range (ATR)
  • TECX 1.30
  • CMCO 0.66
  • MACD
  • TECX 0.54
  • CMCO 0.02
  • Stochastic Oscillator
  • TECX 96.12
  • CMCO 64.20

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

Share on Social Networks: